GlassScriptPhysician profile
Maykel Desir
NPI 1831585876
$1,203.01
in general payments reported to CMS, 2019-2025
10 companies · $24.81 in 2025
The $24.81 reported for 2025 was less than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $879 · 2021: $60.21 · 2022: $106 · 2023: $116 · 2024: $17.82 · 2025: $24.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $816.23 | 2020 | |
| Bioventus LLC | $124.66 | 2020-2024 | Gelsyn-3 |
| Scilex Pharmaceuticals INC. | $88.93 | 2022-2023 | Ztlido |
| Avanos Medical | $77.49 | 2022-2025 | Genvisc 850 Sodium Hyaluronate |
| Orthogenrx INC. | $23.82 | 2021 | |
| Vertos Medical, INC. | $17.69 | 2022 | |
| Medtronic USA, INC. | $15.59 | 2020 | |
| Ibsa Pharma INC. | $13.56 | 2023 | Licart, Tirosint |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
| Redhill Biopharma INC. | $11.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maykel Desir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.